CI vs PTCT · P/E 2.4, rev $274.90B vs rev $806.8M
Cigna Corp (CI) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the CI and PTCT stock pages for the full models.
Not investment advice.